STE
STERIS plc
-1.34 (-0.64%)208.56USD229K成交股數20.3B市值26.3本益比(近四季)3.4股價營收比+7.3%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 3 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.5B+7% | 1.6B+16% | 1.5B+13% | 1.5B+14% | 1.4B-2% | 1.4B+6% | 1.3B+7% | 1.3B+8% | 1.4B | 1.3B | 1.2B | 1.2B |
| 營業成本 | 809M | 891M | 841M | 814M | 763M | 760M | 750M | 707M | 836M | 738M | 692M | 654M |
| 毛利 | 684M+9% | 697M+14% | 656M+13% | 646M+13% | 628M+8% | 610M+9% | 579M+6% | 572M+8% | 583M | 560M | 546M | 529M |
| 毛利率 | 45.8% | 43.9% | 43.8% | 44.2% | 45.1% | 44.5% | 43.6% | 44.7% | 41.1% | 43.2% | 44.1% | 44.7% |
| 研發費用 | 28.6M | 28.8M | 29.5M | 28.2M | 26.4M | 27.4M | 27.0M | 25.6M | – | 25.3M | 26.3M | 24.7M |
| 銷售管理費用 | 370M | 352M | 352M | 350M | 354M | 336M | 329M | 336M | – | 308M | 328M | 307M |
| 營業利益 | 286M+16% | 317M+29% | 273M+24% | 266M+43% | 246M | 245M+8% | 220M+15% | 186M-6% | – | 226M | 192M | 198M |
| 營業利益率 | 19.1% | 19.9% | 18.3% | 18.2% | 17.7% | 17.9% | 16.5% | 14.5% | – | 17.5% | 15.5% | 16.7% |
| 稅後淨利 | 200M+13% | 220M+27% | 193M+29% | 192M+32% | 177M-12983% | 174M+23% | 150M+30% | 145M+18% | −1.4M | 141M | 115M | 124M |
| 淨利率 | 13.4% | 13.9% | 12.9% | 13.1% | 12.8% | 12.7% | 11.3% | 11.4% | -0.1% | 10.8% | 9.3% | 10.4% |
| 稀釋 EPS | – | 2.24+28% | 1.96+30% | 1.94+33% | 1.79-18000% | 1.75+23% | 1.51+30% | 1.46+17% | -0.01 | 1.42 | 1.16 | 1.25 |
| 稀釋股數 | 97.9M | 98.7M | 98.6M | 98.8M | 98.8M | 98.9M | 99.2M | 99.4M | – | 99.4M | 99.4M | 99.2M |
資產負債表 期末餘額
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 482M | 440M | 424M | 319M | 280M | 155M | 172M | 198M | 207M | 196M | 214M | 209M |
| 應收帳款 | 1.0B | 1.1B | 991M | 947M | 947M | 915M | 923M | 893M | 1.0B | 964M | 940M | 888M |
| 存貨 | 712M | 632M | 674M | 659M | 641M | 650M | 689M | 699M | 675M | 856M | 821M | 769M |
| 總資產 | 10.7B | 10.7B | 10.6B | 10.4B | 10.4B | 10.0B | 10.2B | 10.1B | 11.1B | 11.4B | 11.3B | 10.8B |
| 有息負債 | 1.7B | 1.8B | 1.9B | 1.9B | 1.9B | 2.0B | 2.2B | 2.2B | 3.1B | 3.2B | 3.4B | 2.9B |
| 總負債 | 3.5B | 3.5B | 3.4B | 3.4B | 3.4B | 3.6B | 3.6B | 3.7B | 4.7B | 5.0B | 5.1B | 4.6B |
| 股東權益 | 7.2B | 7.2B | 7.2B | 7.0B | 7.0B | 6.4B | 6.6B | 6.4B | 6.3B | 6.4B | 6.2B | 6.2B |
| 負債比 | 32.7% | 33.0% | 32.3% | 32.5% | 33.0% | 35.8% | 35.5% | 37.0% | 42.9% | 43.8% | 45.1% | 42.7% |
| 淨現金(現金 − 有息負債) | −1.2B | −1.4B | −1.5B | −1.6B | −1.6B | −1.9B | −2.0B | −2.0B | −2.9B | −3.0B | −3.2B | −2.7B |
現金流量表 單季
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | 367M-13% | – | – | – | 420M | – | – | 304M+8% | – | – | – | 281M |
| 資本支出 | 87.5M | – | – | – | 93.6M | – | – | 108M | – | – | – | 66.6M |
| 自由現金流 | 280M-14% | – | – | – | 326M | – | – | 196M-9% | – | – | – | 215M |
| 折舊攤銷 | 124M | – | – | – | 119M | – | – | 113M | – | – | – | 138M |
| 買回庫藏股 | 116M | – | – | – | 10.6M | – | 46.4M | 64.2M | – | 2.2M | 489K | 8.7M |
| 現金股利 | 61.4M | – | – | – | 56.2M | – | – | 51.4M | – | – | – | 46.4M |
| 自由現金流率 | 18.7% | – | – | – | 23.5% | – | – | 15.3% | – | – | – | 18.1% |
營收拆解 2026 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2026 年度 · 5.9B
| Healthcare | 4.2B | 70.9% | +8.5% |
|---|---|---|---|
| Applied Sterilization Technologies | 1.1B | 19.2% | +9.6% |
| Life Science | 589M | 9.9% | +8.6% |
地區2026 年度 · 5.9B
| 美國 | 4.3B | 73.0% | +8.1% |
|---|---|---|---|
| Otherforeignlocations | 1.5B | 25.2% | +11.1% |
| 愛爾蘭 | 109M | 1.8% | +1.1% |
產品／服務2026 年度 · 5.9B
| 產品 | 3.1B | 51.6% | +6.6% |
|---|---|---|---|
| 服務 | 2.9B | 48.4% | +11.1% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | 5.9B | +8.7% | 782M | 13.2% | 7.93 | 972M |
| FY2025 | 5.5B | +6.2% | 615M | 11.3% | 6.20 | 778M |
| FY2024 | 5.1B | +13.3% | 378M | 7.4% | 3.81 | 613M |
| FY2023 | 4.5B | +7.4% | 107M | 2.4% | 1.07 | 395M |
| FY2022 | 4.2B | +35.9% | 244M | 5.8% | 2.48 | 397M |
| FY2021 | 3.1B | +2.5% | 397M | 12.8% | 4.63 | 450M |
| FY2020 | 3.0B | +8.9% | 408M | 13.5% | 4.76 | 376M |
| FY2019 | 2.8B | – | 304M | 10.9% | 3.55 | 350M |